ArticleCancer medicine2025
Whole Transcriptome Sequencing Analyzes the Interactions of mRNAs and ncRNAs in Cholangiocarcinoma.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCholangiocarcinoma is a common hepatic malignant tumor with an unfavorable prognosis. Therefore, we systematically evaluated the transcriptomic landscape of CHOL by whole transcriptome sequencing technology in this study and constructed a ceRNA network associated with CHOL.
methodsFirst, whole transcriptome sequencing between the tumor tissues of CHOL and adjacent cancer tissues adjacent to the tumors from six patients with CHOL was performed. Then, a differential expression analysis between the CHOL group and adjacent cancer group was performed to screen significant markers. Subsequently, target gene predictive analysis and co-expression analysis were implemented to construct a ceRNA and protein-protein interaction network in CHOL, and enrichment analysis was performed to investigate gene-related molecular pathways.
resultsThe results showed that there were 761 differentially expressed mRNAs, 47 differentially expressed miRNAs, 61 differentially expressed lncRNAs, and 1481 differentially expressed circRNAs in the adjacent cancer group compared with the CHOL group, respectively. Enrichment analysis of differentially expressed mRNAs showed that the PI3K-Akt, calcium, and MAPK signaling pathways were significantly enriched. Hsa-miR-196b-5p can be a sponge to adsorb lncRNA H19 and 101 downregulated mRNAs, constructing an lncRNA-miRNA-mRNA network. Hsa_circ_0025636, hsa_circ_0057335, hsa-miR-96-5p, and hsa-miR-196b-5p were involved in the circRNA-miRNA-mRNA network. Moreover, five core genes were obtained through PPI interaction analysis, which also played an important role in the ceRNA network.
conclusionsThis study systematically presents a transcriptomic landscape of CHOL and identifies lncRNA/circRNA-associated ceRNA networks that could provide insights for future treatment and prognosis of CHOL, laying a certain foundation for the study of molecular mechanisms and providing novel ideas for its prognosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.